Guangzhou Shifang International Trade Co., Ltd – Trademark Portfolio

Entity Type: 16

Guangzhou Shifang International Trade Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include VAZATISI. The owner is based in Baiyun Dist, Guangzhou.

Room Q1078-1002

Baiyun Dist, Guangzhou 510442 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VAZATISI
VAZATISI
Registered 2021

Trademark Classifications

Guangzhou Shifang International Trade Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Guangzhou Shifang International Trade Co., Ltd have?

Guangzhou Shifang International Trade Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guangzhou Shifang International Trade Co., Ltd file in?

Guangzhou Shifang International Trade Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Guangzhou Shifang International Trade Co., Ltd's most well-known trademarks?

Guangzhou Shifang International Trade Co., Ltd's registered trademark portfolio includes well-known marks such as VAZATISI. These are among 1 currently registered trademark in the portfolio.

What is Guangzhou Shifang International Trade Co., Ltd's trademark registration success rate?

Guangzhou Shifang International Trade Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.